Gregg’s Diabetes Identifies GNS as One of a Handful of Companies Focused on Market Access
The 21st Century Cures Act makes “Real World Evidence” a buzz word in pharma and payer circles, and justifiably so. For the uninitiated, “Real World Evidence” (RWE) is a term that has received much and attention and debate as a core component of the 21st Century Cures Act: a bill that received much press coverage […]
GNS Healthcare Study with Pfizer Reveals Discovery of Novel Clinical Risk Factors Driving Progression to Type 2 Diabetes and Prediabetes
Published by the Journal of Diabetes Science and Technology, Discoveries Result From Computer Models Created From EHR Data and Causal Machine Learning Technology CAMBRIDGE, Mass. – Feb. 29, 2016 – GNS Healthcare (GNS), a leading precision medicine company that applies causal machine learning technology to match health interventions to individual patients and discover new intervention […]
GNS Healthcare CEO Colin Hill to Address AHIP Institute 2015 General Session
CAMBRIDGE, Mass. – May 26, 2015 – Precision medicine pioneer Colin Hill will be a featured speaker at AHIP Institute 2015, offering a real-world view of how precision medicine is converging with population health to enable truly individualized interventions and dramatically improve return on population health investments. Hill is chairman and CEO of GNS Healthcare, […]
Aetna.com: Using “Big Data” to Predict – and Improve – Your Health
Aetna’s Innovation Labs teamed up with GNS Healthcare to use “big data” to predict the one-year risk of developing metabolic syndrome. The groups used computer models to study information from 37,000 members of one of Aetna’s employer customers. Read the complete article here…